We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Imagion Biosystems is a diagnostics & research business based in Australia. Imagion Biosystems shares (IBX) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Imagion Biosystems has a trailing 12-month revenue of around $2.9 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
Overall broker
Our top pick for
Low-cost broker
| 52-week range | $0.026 - $0.105 |
|---|---|
| 50-day moving average | $0.0388 |
| 200-day moving average | $0.0614 |
| Target price | N/A |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.006 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.044
| 1 week (2022-06-29) | 51.72% |
|---|---|
| 1 month (2022-06-06) | 12.82% |
| 3 months (2022-04-06) | -24.14% |
| 6 months (2022-01-06) | -39.73% |
| 1 year (2021-07-06) | -53.19% |
|---|---|
| 2 years (2020-07-06) | -2.22% |
| 5 years (2017-07-06) | -69.06% |
| Revenue TTM | $2.9 million |
|---|---|
| Gross profit TTM | $151,534 |
| Return on assets TTM | -26.63% |
| Return on equity TTM | -45.96% |
| Profit margin | -210.98% |
| Book value | 0.012 |
| Market capitalisation | $47.1 million |
TTM: trailing 12 months
We're not expecting Imagion Biosystems to pay a dividend over the next 12 months.
Over the last 12 months, Imagion Biosystems 's shares have ranged in value from as little as $0.026 up to $0.105. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Imagion Biosystems 's is 3.0965. This would suggest that Imagion Biosystems 's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to detect cancer. Imagion Biosystems Limited has a collaborative research program with Patrys Limited to use the combined technologies for enhancing brain tumor imaging and diagnosis; and a joint development agreement with Global Cancer Technology, Inc. to develop GCT's novel nanoscintillator technology for the treatment of breast cancer. The company was incorporated in 2016 and is based in San Diego, California.
Everything we know about the Australia Sunny Glass Group IPO, plus information on how to buy in.
Steps to owning and managing Kincora Copper shares.
Everything we know about the Dragon Mountain Gold IPO, plus information on how to buy in.
Steps to owning and managing Arcadia Minerals shares.
Steps to owning and managing Nexgen Energy shares.
Steps to owning and managing Keypath Education shares.
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
Steps to owning and managing EBR Systems shares.
Steps to owning and managing 5E Advanced Materials shares.
